Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion-Reference-Cited by-同舟云学术

Predictors of CD4 cell recovery following initiation of antiretroviral therapy among HIV-1 positive patients with well-estimated dates of seroconversion

Published:2017-12-01 Issue:3 Volume:19 Page:184-194
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Stirrup OT¹^ORCID,Copas AJ¹,Phillips AN²,Gill MJ³,Geskus RB⁴⁵⁶⁷,Touloumi G⁸,Young J⁹,Bucher HC⁹,Babiker AG¹,

Affiliation:

1. MRC Clinical Trials Unit; University College London; London UK

2. Research Department of Infection & Population Health; University College London; London UK

3. Department of Medicine; University of Calgary; Calgary AB Canada

4. Department of Clinical Epidemiology, Biostatistics and Bioinformatics; Academic Medical Center (AMC); Amsterdam The Netherlands

5. Department of Infectious Diseases; Public Health Service of Amsterdam; Amsterdam The Netherlands

6. Oxford University Clinical Research Unit; Wellcome Trust Major Overseas Programme; Ho Chi Minh City Vietnam

7. Nuffield Department of Clinical Medicine; Centre for Tropical Medicine and Global Health; University of Oxford; Oxford UK

8. Department of Hygiene, Epidemiology and Medical Statistics, Medical School; National and Kapodistrian University of Athens; Athens Greece

9. Basel Institute for Clinical Epidemiology and Biostatistics; University Hospital Basel and University of Basel; Basel Switzerland

Funder

European Union Seventh Framework Programme

Medical Research Council

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hiv.12567/fullpdf

Reference39 articles.

1. CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater;Gras;J Acquir Immune Defic Syndr,2007

2. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study;Kaufmann;Arch Intern Med,2003

3. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression;Moore;Clin Infect Dis,2007

4. Long-term increase in CD4+ T-cell counts during combination antiretroviral therapy for HIV-1 infection;Lok;AIDS,2010

5. Long-term trends in CD4 cell counts and impact of viral failure in individuals starting antiretroviral therapy: UK Collaborative HIV Cohort (CHIC) study;Hughes;HIV Med,2011

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combining CD4 count, CD8 count and CD4/CD8 ratio to predict risk of mortality among HIV-positive adults after therapy: a group-based multi-trajectory analysis;Frontiers in Immunology;2023-12-06

2. Immune recovery among Romanian HIV/AIDS patients receiving darunavir/ritonavir or darunavir/cobicistat regimens in cART management: A three-year study;Biomedicine & Pharmacotherapy;2023-05

3. CASCADE protocol: exploring current viral and host characteristics, measuring clinical and patient-reported outcomes, and understanding the lived experiences and needs of individuals with recently acquired HIV infection through a multicentre mixed-methods observational study in Europe and Canada;BMJ Open;2023-05

4. The Effect of HIV Treatment Interruption on Subsequent Immunological Response;American Journal of Epidemiology;2023-04-12

5. Low pre-ART CD4 count is associated with increased risk of clinical progression or death even after reaching 500 CD4 cells/μL on ART;PLOS ONE;2023-03-30